VEGF has also been shown to increase the invasiveness of colorectal cancer cells or myeloma cells [15,16], and VEGFR1-blocking antibody was reported to inhibit the VEGF-induced invasiveness of these cells [15,16]. The gene discussed is VEGFA; the disease is plasma cell myeloma.